Nov 4, 6:31 AM ET
ESAB reported record third-quarter 2026 net sales of $825 million, up 13.3%, with core organic sales up 2.3%. Diluted GAAP earnings from continuing operations fell to $0.61 per share from $1.04 a year earlier, and the company lowered its full-year 2026 core adjusted EBITDA forecast to $603 million to $607 million from $615 million to $625 million, for shareholders a clear reduction in expected profit.
- Third-quarter net sales were $824.5 million, up from $727.8 million; core organic sales growth was 2.3%.
- Third-quarter net income from continuing operations attributable to ESAB was $41 million, or $0.61 per diluted share, versus $1.04 a year earlier.
- Third-quarter core adjusted EBITDA was $156 million, up 17.0%, with a 19.8% margin.
- Full-year 2026 core adjusted EPS outlook was lowered to $5.28 to $5.33 from $5.40 to $5.50; core organic sales growth outlook was cut to 1.6% to 2.0% from 2.0% to 4.0%.
Read the filing on SEC.gov ↗
Aug 6, 6:31 AM ET
ESAB reported second-quarter 2026 net sales of $808 million, up 12.9% from a year earlier, with core organic growth of 2.5%. Diluted GAAP earnings per share fell to $0.54 from $1.09, and core adjusted diluted EPS was $1.33 versus $1.36, while the company raised its full-year 2026 core adjusted EBITDA forecast to $615 million to $625 million.
- Q2 net sales were $808 million, up 12.9% reported and 2.5% on a core organic basis versus the prior-year quarter.
- Diluted GAAP EPS was $0.54 versus $1.09 a year earlier; core adjusted diluted EPS was $1.33 versus $1.36.
- 2026 core adjusted EBITDA outlook raised to $615 million–$625 million from $575 million–$595 million; core sales growth outlook raised to 11.0%–14.0% from 6.0%–9.0%.
- The Eddyfi acquisition closed one month ahead of schedule.
Read the filing on SEC.gov ↗
Jun 12, 6:36 AM ET
On June 10, 2026, ESAB appointed Mitchell P. Rales as Executive Chair of the Board and approved performance-based stock option awards for him, CEO Shyam P. Kambeyanda and other senior managers. The awards vest only if the stock meets price hurdles of $140, $170 and $200 over a four-year performance period, which gives shareholders a direct link between management pay and share price. The filing also names Rhonda Jordan as Lead Independent Director.
- Mitchell P. Rales appointed Executive Chair effective June 10, 2026; he was previously Chairman, appointed in April 2022
- Rales award covers 1,200,000 shares; Kambeyanda award covers 580,552 shares
- Exercise price of $82.92 per share, equal to the NYSE closing price on the June 10, 2026 grant date, with a seven-year term ending June 9, 2033
- Each award vests in three tranches tied to $140, $170 and $200 stock price hurdles measured over a 30-day average during the performance period
Read the filing on SEC.gov ↗
Jun 2, 6:41 AM ET
ESAB completed its acquisition of Eddyfi Holding Inc. on June 1, 2026, paying $1.45 billion in cash, subject to customary purchase price adjustments. The company financed the deal with cash on hand, a senior notes offering, and private placements of Series A Mandatory Convertible Preferred Stock and common stock, which add new equity for shareholders to consider. ESAB said its second-quarter results will include one month of Eddyfi and that it will provide updated full-year guidance on its second-quarter earnings call.
- Eddyfi acquisition closed June 1, 2026 for $1.45 billion in cash, subject to customary adjustments for cash, debt, transaction expenses and net working capital.
- Private placements completed June 1, 2026: 175,000 Series A preferred shares for about $175.0 million and 1,254,255 common shares for about $143.0 million.
- Preferred pays a 6.50% cumulative dividend ($65.00 per share per year) and mandatorily converts into 7.1806 to 8.2576 common shares, about three years after issue.
- Second-quarter results will include one month of Eddyfi, which was not reflected in the outlook given on May 7; updated full-year guidance to follow on the second-quarter earnings call.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.